Diane E. Hasz

1.2k total citations
30 papers, 947 citations indexed

About

Diane E. Hasz is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Diane E. Hasz has authored 30 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Diane E. Hasz's work include Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Diane E. Hasz is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (4 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Diane E. Hasz collaborates with scholars based in United States and France. Diane E. Hasz's co-authors include Peter M. Anderson, Emmanuel Katsanis, I. Dodd Wilson, Jeffrey S. Klausner, Michael Morris, Augusto C. Ochoa, Chand Khanna, Daniel A. Saltzman, Arnold S. Leonard and Sandra M. Kelly and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Gastroenterology.

In The Last Decade

Diane E. Hasz

30 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diane E. Hasz United States 18 313 289 211 203 176 30 947
Jeffrey N. Bryan United States 21 155 0.5× 369 1.3× 668 3.2× 112 0.6× 285 1.6× 89 1.5k
Ravi B. Patel United States 20 321 1.0× 285 1.0× 268 1.3× 103 0.5× 45 0.3× 63 1.4k
Joseph D. Ferrari United States 11 548 1.8× 357 1.2× 100 0.5× 21 0.1× 77 0.4× 14 1.0k
Genc Basha Canada 17 541 1.7× 672 2.3× 68 0.3× 33 0.2× 91 0.5× 28 1.3k
Sunil J. Advani United States 28 280 0.9× 717 2.5× 128 0.6× 121 0.6× 600 3.4× 55 1.8k
Mario Filion Canada 15 243 0.8× 689 2.4× 38 0.2× 28 0.1× 233 1.3× 31 1.2k
Robyn Elmslie United States 22 442 1.4× 273 0.9× 848 4.0× 243 1.2× 465 2.6× 29 1.3k
Samuel Castro United States 6 131 0.4× 338 1.2× 60 0.3× 577 2.8× 164 0.9× 12 1.1k
Samuel Salzberg Israel 21 274 0.9× 420 1.5× 102 0.5× 44 0.2× 175 1.0× 62 1.0k
Ying Waeckerle‐Men Switzerland 19 692 2.2× 371 1.3× 117 0.6× 16 0.1× 52 0.3× 30 1.1k

Countries citing papers authored by Diane E. Hasz

Since Specialization
Citations

This map shows the geographic impact of Diane E. Hasz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane E. Hasz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane E. Hasz more than expected).

Fields of papers citing papers by Diane E. Hasz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane E. Hasz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane E. Hasz. The network helps show where Diane E. Hasz may publish in the future.

Co-authorship network of co-authors of Diane E. Hasz

This figure shows the co-authorship network connecting the top 25 collaborators of Diane E. Hasz. A scholar is included among the top collaborators of Diane E. Hasz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane E. Hasz. Diane E. Hasz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sachs, Zohar, Hoa Nguyen, Craig E. Eckfeldt, et al.. (2016). Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency. Haematologica. 101(10). 1190–1199. 12 indexed citations
2.
Wiesner, Stephen M., Jennifer L. Geurts, Miechaleen D. Diers, et al.. (2011). Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. American Journal of Hematology. 86(7). 579–585. 5 indexed citations
3.
Morgan, Kelly, Matthew Rowley, Stephen M. Wiesner, et al.. (2007). The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells. Leukemia Research. 31(8). 1107–1113. 8 indexed citations
4.
Kim, Andrew, Kelly Morgan, Diane E. Hasz, et al.. (2006). β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. Blood. 109(4). 1687–1691. 21 indexed citations
5.
Morgan, Kelly, et al.. (2002). Signaling after NF1 Gene Loss with GM-CSF Receptor Blockade and Gene Regulation with Neurofibromins GAP Related Domain in Myeloproliferative Disease. Blood. 100(11). 237. 1 indexed citations
6.
Dupuy, Adam J., Kelly Morgan, Friederike C. von Lintig, et al.. (2001). Activation of the Rap1 Guanine Nucleotide Exchange Gene,CalDAG-GEF I, in BXH-2 Murine Myeloid Leukemia. Journal of Biological Chemistry. 276(15). 11804–11811. 56 indexed citations
7.
Khanna, Chand, Peter M. Anderson, Diane E. Hasz, et al.. (1997). Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer. 79(7). 1409–1421. 105 indexed citations
8.
Saltzman, Daniel A., Emmanuel Katsanis, Charles P. Heise, et al.. (1997). Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: A novel antitumor agent?. Journal of Pediatric Surgery. 32(2). 301–306. 55 indexed citations
9.
Saltzman, Daniel A., Emmanuel Katsanis, Charles P. Heise, et al.. (1997). Patterns of Hepatic and Splenic Colonization by an Attenuated Strain of Salmonella typhimurium Containing the Gene for Human Interleukin-2: A Novel Anti-Tumor Agent. Cancer Biotherapy and Radiopharmaceuticals. 12(1). 37–45. 18 indexed citations
10.
Khanna, Chand, J. Clifford Waldrep, Peter M. Anderson, et al.. (1997). Nebulized Interleukin 2 Liposomes: Aerosol Characteristics and Biodistribution. Journal of Pharmacy and Pharmacology. 49(10). 960–971. 37 indexed citations
11.
Saltzman, Daniel A., Charles P. Heise, Diane E. Hasz, et al.. (1996). Attenuated Salmonella typhimurium Containing Interleukin-2 Decreases MC-38 Hepatic Metastases: A Novel Anti-tumor Agent. Cancer Biotherapy and Radiopharmaceuticals. 11(2). 145–153. 80 indexed citations
12.
Anderson, Peter M., et al.. (1994). Cytokines in liposomes: Preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-γ. Cytokine. 6(1). 92–101. 74 indexed citations
13.
Ramsay, NK, et al.. (1992). Anti-CD3 + interleukin-2 stimulation of marrow and blood: comparison of proliferation and cytotoxicity. Blood. 80(7). 1846–1853. 17 indexed citations
14.
Anderson, Peter M., Emmanuel Katsanis, Susan Sencer, et al.. (1992). Depot Characteristics and Biodistribution of Interleukin-2 Liposomes, Importance of Route of Administration. Journal of Immunotherapy. 12(1). 3–31. 53 indexed citations
15.
16.
Ochoa, Augusto C., et al.. (1989). Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.. PubMed. 49(4). 963–8. 51 indexed citations
17.
Hasz, Diane E., et al.. (1982). Spontaneous aggregation of native immunoglobulins in hypoalbuminemic serum.. PubMed. 9(1). 13–7. 5 indexed citations
18.
Hasz, Diane E., et al.. (1979). Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease. Gastroenterology. 76(6). 1380–1385. 31 indexed citations
19.
Hasz, Diane E., et al.. (1979). The effect of heat inactivation of serum on the detection of immune complexes.. PubMed. 1(4). 321–7. 1 indexed citations
20.
Hasz, Diane E., et al.. (1979). Studies on the nature of heat-labile anti-complementary activity in normal human serum.. PubMed. 37(2). 310–22. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey N. Bryan Breakdown of academic impact, for papers by Ravi B. Patel Breakdown of academic impact, for papers by Joseph D. Ferrari Breakdown of academic impact, for papers by Genc Basha Breakdown of academic impact, for papers by Sunil J. Advani Breakdown of academic impact, for papers by Mario Filion Breakdown of academic impact, for papers by Robyn Elmslie Breakdown of academic impact, for papers by Samuel Castro Breakdown of academic impact, for papers by Samuel Salzberg Breakdown of academic impact, for papers by Ying Waeckerle‐Men
Rankless by CCL
2026